Officers in Northampton also found ‘sophisticated packaging and manufacturing equipment’ as well as £20,000 in cash.

The first illicit production facility for weight loss medicine found in the UK has been dismantled. The discovery, in ...

People, I think, have started looking outside the box when it comes to health care. And they’re turning more to wellness and ...

Midlife weight gain is a persistent challenge for many women, but emerging research suggests hormone therapy may enhance response to glucagon-like peptide-1 (GLP-1)–based treatments.

Mumbai, Oct. 24 -- "The introduction of a second brand of Tirzepatide in India through our commercial agreement with Cipla ...

Clinical studies have shown that participants using Tirzepatide experienced up to 22% body weight reduction over 72 weeks, ...

Semaglutide is a so-called GLP-1 drug: a hormone mimicker meant to treat type 2 diabetes. Our bodies secrete natural GLP-1 hormones after we eat to help start insulin production, which regulates blood ...

Cipla and Eli Lilly India have announced an agreement to distribute a type 2 diabetes drug, tirzepatide, under the new brand ...

Eli Lilly ( NYSE: LLY) has partnered with India's Cipla to market its weight-loss medication Tirzepatide under a new brand in ...